ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
6.92
-0.23
(-3.22%)
6.969
0.049
(0.71%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

ALT News

Official News Only

ALT Discussion

View Posts
Monksdream Monksdream 2 months ago
ALT, new 52 week low
πŸ‘οΈ0
Kam8 Kam8 3 months ago
Thank you so much for your kind reply.👍️👍️👍️
πŸ‘οΈ0
akamaii akamaii 3 months ago
I think after mash data if it’s like last trials you can bet for a deal or buyout
👍 1 😍 1
Kam8 Kam8 3 months ago
BO soon???
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
ALT, new 52 week low
πŸ‘οΈ0
Mark102 Mark102 6 months ago
Still Holding here
As far as buyout and the OS you're looking at roughly 7 billion = 100 a share
10 billion = 140

👍 1
Mark102 Mark102 10 months ago
As promised I don't see any dilution in the filing. Shorts are in trouble
👍 1
Mark102 Mark102 10 months ago
Float is Locked and over 23 million naked shares Short. Shorts have failed Miserably at shaking out Retail and can't cover without a massive loss.
Price Targets
Partner 50 to 75
Buyout 140 to 200
👍 1
Mark102 Mark102 11 months ago
https://forextv.com/top-news/altimmune-announces-publication-of-clinical-study-of-pemvidutide-in-metabolic-dysfunction-associated-steatotic-liver-disease-masld-in-journal-of-hepatology/
👍 1 💯 1
Mark102 Mark102 11 months ago
IT'S HAPPENING
πŸ‘οΈ0
Mark102 Mark102 11 months ago
Beautiful Bull Flag
πŸ‘οΈ0
girlfriend girlfriend 12 months ago
Well....not quite but a nice pop anyways this week.
πŸ‘οΈ0
Mark102 Mark102 12 months ago
Last chance next week above 20
πŸ‘οΈ0
Mark102 Mark102 12 months ago
It's being shorted by its competitors not tutes. . An advisor from Lilly is making the presentations of pemvi data this weekend.its what you know not what some want you to believe.
👍 1
brfv11 brfv11 1 year ago
Not a chance at 60. Shorts are playing this one perfectly. Investors are just not interested in ALT. Good luck.
👍 1
Mark102 Mark102 1 year ago
Shorts looking weak and vulnerable today any trading room with the funds could squeeze this to 60 easy
πŸ‘οΈ0
Mark102 Mark102 1 year ago
Goldman Sachs been short stacking here for months and they are hosting the fireside tomorrow. I'm loading up today
πŸ‘οΈ0
brfv11 brfv11 1 year ago
Time to admit shorty got this one right! This one is going all the way down.
Merger/ buyout what a joke.
πŸ‘οΈ0
akamaii akamaii 1 year ago
This Wednesday we hope data rules. Give us data 📈
πŸ‘οΈ0
akamaii akamaii 1 year ago
Going long for a year 75 target or 50 plus
πŸ‘οΈ0
Mt. Blanc Mt. Blanc 1 year ago
So much for my ALT prediction.

The stock slipped to $7 and may be cratering more since it's getting no love.

Maybe ALT is a $5 stock or lower if buyers aren't interested.

mb
πŸ‘οΈ0
Mt. Blanc Mt. Blanc 1 year ago
Radar. ALT $11- $12

Getting picked up.

mb
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
ALT over $10
Next day settlement begins 5/28 per SEC mandate
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
ALT 10Q due 3/27
Next day settlement begins 5/28
πŸ‘οΈ0
saigai saigai 1 year ago
patiently waiting.. for sure something in the way of news is right there and it can only be a plus.. i want the buyout.. let say 4 billion.. 80 bucks a share..gl
πŸ‘οΈ0
Mark102 Mark102 1 year ago
Buyout? Partnership? In less than 9 trading days we will find out.
πŸ‘οΈ0
Mark102 Mark102 1 year ago
BUCKLE UP. going to break 15 soon
πŸ‘οΈ0
saigai saigai 1 year ago
a good read
https://www.rcplondon.ac.uk/news/world-obesity-day-let-s-talk-about-drugs
πŸ‘οΈ0
saigai saigai 1 year ago
slow and steady is healthy as the data goes as well.. fast weight loss is never good and the deeper dive into the data im sure will find that Alt has a wider profile a safer profile as it relates to muscle loss and bone density. time will tell...in any case the real value here is the undiscovered uses.. wide profile more mkts...long and strong ...
πŸ‘οΈ0
Mt. Blanc Mt. Blanc 1 year ago
ALT @ $12?

Interesting

mb
πŸ‘οΈ0
saigai saigai 1 year ago
institutional ownership from nasdaq site
https://www.nasdaq.com/market-activity/stocks/alt/institutional-holdings
πŸ‘οΈ0
saigai saigai 1 year ago
big volume wrong direction for now
πŸ‘οΈ0
saigai saigai 1 year ago
a good read
https://finance.yahoo.com/news/weight-loss-drugs-patients-lose-134837816.html
πŸ‘οΈ0
saigai saigai 1 year ago
and a few more...
πŸ‘οΈ0
saigai saigai 1 year ago
you wont be able to chase this..you either in before the news or outside looking in.. patience of a saint..
πŸ‘οΈ0
saigai saigai 1 year ago
driving me nutz but i wont sell this until !!!
πŸ‘οΈ0
murocman murocman 1 year ago
Post from another board relevant to ALT:

GLP-1 drugs will_be supply-constrained for_a_few_years, according to the NVO and LLY webcasts at JPM. All in-house and CMO capacity suitable for manufacturing injected GLP-1 drugs is already in service. Moreover, the eventual uptake of oral GLP-1 drugs will not ease the manufacturing bottleneck as much as people might think because the low bioavailability of the oral agents requires large amounts of API.
πŸ‘οΈ0
AGORDON AGORDON 1 year ago
Altimmune, Inc.
(Nasdaq - ALT) $12/share
Market cap = $644M
Cash = $140M
Cash Burn rate = ($76)/Y
Catalysts:
Pemvidutide - Weight loss drug. Peptide based GLP-1/Glucagon dual receptor agonist. Phase 2 results were respectable. At 48 weeks, for 2.4mg (high dose), weight loss of -15.6% (on the low end of the expected 15-20%)., but comparable to Mounjaro. The TRAEs appear to be less than Mounjaro's. The drug did reduce triglycerides.
HepTCell - an immunotherapeutic for Chronic Hepatitis B. In Phase 2 trials. Next read out could be in April, 2024.
πŸ‘οΈ0
Mark102 Mark102 1 year ago
I was wrong ALT is attending the JPM Let's get this deal done.
πŸ‘οΈ0
saigai saigai 1 year ago
thanks a lot.. im on a new computer.. id rather have oral surgery than learn a new computer
πŸ‘οΈ0
Mark102 Mark102 1 year ago
Data is in check Twitter. Weight loss is a 100 billion market. The results on the liver data show a 100 % reduction of fat at the highest dose. That's a 40 billion market.
Now why is ALT not attending the JPM conference this week? Stay tuned
πŸ‘οΈ0
saigai saigai 1 year ago
im hanging around bewteen the two potential mkts for their drug its too crazy to even think out loud lets see what the data says.. if its good or really good. all hell will break out
πŸ‘οΈ0
Mark102 Mark102 1 year ago
Float is locked, tutes trying to shake few out but this is a done deal IMO
πŸ‘οΈ0
saigai saigai 1 year ago
this is a powder keg...
πŸ‘οΈ0
saigai saigai 1 year ago
i believe if they wanted to they could have closed a deal by now but they wait till after the new data.. i wonder why.. there is no way for this to go but way up from here..glta
πŸ‘οΈ0
Mark102 Mark102 1 year ago
Been Holding since 6. Buyout or partnership is imminent.
πŸ‘οΈ0
1hot toddy 1hot toddy 1 year ago
HUGE BUYS NOW 10K BUY $100K BUY $$$$$$$$$$$$$$$$$$
πŸ‘οΈ0
Bud-Wiser Bud-Wiser 1 year ago
Nice comeback today -I’m back in
πŸ‘οΈ0
1hot toddy 1hot toddy 1 year ago
WOOOOOOOOOOOW 10K AND 9100 SHARE BUYS 2-$100,000 BUYS $$$$$$$$$$$$$$$$$$$$$$$$$$$$$
BABY MONSTER HERE
πŸ‘οΈ0
eyeownu eyeownu 1 year ago
got dammmmmmmmmmm. oprah must be buying out the company
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock